skip to Main Content

November 15, 2021
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

November 11, 2021
Update on HIV Vaccine Research
Publication
Developing an HIV vaccine is a difficult scientific challenge, but remains a critical priority. This handout provides an update on HIV vaccine research and a summary of results from the efficacy trials that have been conducted to date, and it was developed in collaboration with the Black AIDS Institute, HIV…

October 26, 2021
HIV Research Advocacy Fact Sheet
Publication
HIV advocacy laid the foundation for much of the work we do today. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition. The handout provides a summary of the history of HIV research advocacy and updates on new HIV advocacy…

October 26, 2021
New HIV Prevention Research Fact Sheet
Publication
HIV prevention research continues to rapidly evolve. The availability of pre-exposure prophylaxis (PrEP) has necessitated the development of new approaches to testing the efficacy of additional biomedical HIV prevention options. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition. The…

October 26, 2021
Broadly Neutralizing Antibodies for HIV Prevention Fact Sheet
Publication
HIV-specific broadly neutralizing antibodies (bNAbs) could have a role in treating, preventing, or even curing HIV. Some HIV-specific bNAbs are already being tested in clinical trials, both for prevention and treatment. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition.…

October 26, 2021
What’s on the Horizon for Long-Acting Pre-Exposure Prophylaxis (PrEP)? Fact Sheet
Publication
Long-acting pre-exposure prophylaxis (PrEP) will be a groundbreaking HIV prevention tool. The approach provides an option to receive intermittent doses of PrEP instead of taking daily pills. This handout provides an update on the development of long-acting PrEP and future prospects for the approach. The handout was developed in collaboration…

October 26, 2021
HIV Science Fact Sheet
Publication
HIV science can be difficult to understand. This handout explains some of the unique scientific challenges presented by HIV. The handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition.

October 22, 2021
Grant Officer
TAG is seeking a dynamic, highly motivated, and organized Grant Officer to support grant and fundraising efforts.

October 19, 2021
TAG and COVID-19 Prevention Network Fact Sheets
Publication
These three fact sheets were developed by TAG in partnership with the COVID-19 Prevention Network (CoVPN) and the Black AIDS Institute (BAI), and they aim to foster community understanding of COVID-19 vaccine research and development, as well as highlight community perspectives on the topic.

October 7, 2021
TAGline October 2021
TAGline
Delivering on the Promise of Long-Acting Forumulations delves deep into the development of long-acting formulations for the treatment and prevention of infectious diseases like HIV, tuberculosis, hepatitis C, and malaria. Long-acting medications have become common for conditions such as osteoporosis and schizophrenia, and they’re even used for birth control.

September 14, 2021
The Future of HIV Biomedical Prevention Research
Webinar / Presentation
Abraham Johnson, TAG’s Community Engagement Officer, presented this webinar with Carl Dieffenbach, Director of the Division of AIDS at the National Institute for Allergy and Infectious Diseases (NIAID), where he provided an update on the future of biomedical HIV prevention research.

August 27, 2021
Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing
Statement / Press
TAG’s comprehensive analysis found that the public invested at least $252 million USD in the research and development of GeneXpert diagnostic technology, which stands in stark contrast to the lack of affordable pricing and favorable service and maintenance terms from the diagnostics company Cepheid.

August 5, 2021
Comments to NIH Leadership Regarding the Proposed Advanced Research Projects Agency for Health
Letter / Comment
In response to the Biden administration’s intention to create a new research agency under the NIH called the Advanced Research Projects Agency for Health (ARPA-H), TAG and AVAC were invited to present remarks and guidance on the behalf of the Federal AIDS Policy Partnership and Research Work Group (RWG).

July 16, 2021
2021 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

July 9, 2021
TAG Testimonies on Funding Priorities FY22 to Senate LHHS and Related Agencies
Letter / Comment
On June 24, TAG submitted testimony to the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies outlining funding priorities for fiscal year 2022.

Back To Top